Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost side effects from semaglutide pills are gastrointestinal, occur early in treatment, and settle as your body adjusts — but knowing which symptoms are expected and which need prompt attention makes a meaningful difference. The Wegovy tablet (oral semaglutide 25mg maintenance dose) was approved by the MHRA in June 2026 as the UK's first oral GLP-1 medicine licensed for weight management, and its side-effect profile reflects both its mechanism and the relatively high oral dose required. These are prescription-only medicines; a prescriber assesses your suitability and talks through your individual risk profile before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
People often assume swapping from an injection to a tablet automatically means a gentler ride. With semaglutide, the evidence suggests otherwise. In the OASIS 4 phase-3 trial, 74% of participants on oral semaglutide reported gastrointestinal side effects, compared with 42.2% on placebo. That is a higher rate than typically seen with the weekly injection in the STEP trials, largely because the oral route requires a much higher dose to achieve comparable absorption, and more of the medicine reaches the gut before the bloodstream.
This is not a reason to avoid the tablet. It is a reason to go in with accurate expectations rather than pleasant ones. The vast majority of GI effects were classed as mild to moderate in the trial, and they followed a predictable pattern: most noticeable in the first two to four weeks of a new dose stage, then easing as the body adapts. The semaglutide tablet treatment page covers the full dosing schedule if you want to understand how the titration works.
The practical implication: plan the early weeks of each dose increase with some awareness. Fatty, rich or spicy meals amplify nausea. Eating slowly, keeping portions smaller, and staying well hydrated all help. Think of the tablet before the kettle goes on, an empty stomach, a sip of water, then your morning routine. That sequence matters clinically, not just as a ritual.
Nausea is the one people ask about most. It tends to peak in the first week or two after a dose increase and then diminish, rather than being a constant companion throughout treatment. Vomiting is less common than nausea but does occur, particularly if the titration schedule moves faster than the body is ready for, one of the reasons the dose ladder exists. Diarrhoea and constipation can both feature, sometimes alternating. Burping, bloating and indigestion round out the GI picture.
Beyond the gut, some people notice fatigue and headaches early in treatment, likely related to reduced calorie intake as appetite falls. Dizziness is occasionally reported, particularly on standing, and is worth flagging to your prescriber if it recurs. Injection-site reactions obviously do not apply here (one genuine advantage of the oral form) but the tablet carries its own tolerability curve.
The NHS semaglutide medicines page lists the full frequency breakdown of reported effects for reference. For dose-specific questions about how side effects present at particular stages, the oral semaglutide side effects overview goes into more detail on what changes as the dose increases.
Most side effects from the Wegovy tablet do not require urgent attention. Some do. Knowing the difference is what this section is for.
Get medical help promptly if you experience severe, persistent abdominal pain that spreads to your back, with or without vomiting. This may indicate acute pancreatitis, which the MHRA formally flagged for GLP-1 medicines in its January 2026 Drug Safety Update. It is uncommon, but it is serious. Stop treatment and seek same-day assessment.
Signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, rapid heart rate) need emergency care. Similarly, if repeated vomiting or diarrhoea leaves you unable to keep fluids down for more than a day, the resulting dehydration can affect kidney function. Seek advice rather than waiting it out.
Gallbladder problems, including gallstones, have been reported with GLP-1 medicines as a class. Upper-right abdominal pain, especially after meals, warrants a call to your GP or prescriber. And if you notice any significant change in mood or have thoughts of self-harm while on treatment, contact a healthcare professional without delay.
For non-urgent questions or side effects that are uncomfortable but not alarming, our aftercare team is available seven days a week. You can also explore broader Wegovy pill side effects information if you want to compare how this applies across the medicine as a whole.
People switching from the weekly semaglutide injection to the tablet sometimes expect a seamless continuation. It is worth understanding that oral bioavailability of semaglutide is much lower, the tablet dose reaches 25mg at maintenance precisely because the gut absorbs only a fraction of what is swallowed. Patients established on the 2.4mg weekly injection may move directly to the 25mg tablet under prescriber guidance, but side effects can still re-emerge at the transition, even for people who tolerated the injection well.
The administration rules become more important, not less. If you want to know what to expect at the earlier stages of that process, our page on semaglutide 7mg tablets side effects explains what most people notice when they are just starting out on the dose ladder. The tablet must be taken on an empty stomach with no more than around 120ml of plain water, and nothing else (no coffee, no other medicines, no food) for at least 30 minutes afterwards. Deviating from this blunts absorption and can also increase GI discomfort.
Our clinical team reviews every patient individually before any switch, and those details (your history on the injection, your current dose, any side effects you experienced) all inform that assessment. The semaglutide tablets side effects page covers the transition question in more depth, and if you are moving into the higher range, our page on semaglutide 14mg tablets side effects sets out what tends to shift as the dose steps up. If you are yet to start treatment and want to understand your options, our weight-loss treatment overview sets out what is available.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.